Oxford BioMedica (OTCMKTS:OXBDF) Hits New 52-Week High - Here's Why

Key Points

• Oxford BioMedica shares reached a new 52-week high of $8.41, significantly up from the previous close of $7.30.
• The company's stock has shown strong performance with a 50-day moving average of $7.12 and a 200-day moving average of $5.19.
• Oxford BioMedica is known for its LentiVector platform technology, which enhances gene delivery by addressing safety and delivery issues found in earlier systems.

Oxford BioMedica (OTCMKTS:OXBDF - ) shares reached a new 52-week high during trading on Tuesday . The company traded as high as $8.41 and last traded at $8.41, with a volume of 10000 shares changing hands. The stock had previously closed at $7.30.

Oxford BioMedica Price Performance

The stock has a 50-day moving average price of $7.12 and a two-hundred day moving average price of $5.19.

Oxford BioMedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.